Luca Lancerotto

Luca Lancerotto

Auto-generated profile, based on publicly available information

Luca Lancerotto

Tissue Engineering and Wound Healing Laboratory, Division of Plastic Surgery, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass., Institute of Plastic Reconstructive and Aesthetic Surgery, University of Padova, Padova, Italy

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2012
Verified
Journal Article
Closed access
LLLuca Lancerotto
Luca Lancerotto
ITIlaria Tocco
Ilaria Tocco
RSRoberto Salmaso
Roberto Salmaso
VVVincenzo Vindigni
Vincenzo Vindigni
FBFranco Bassetto
Franco Bassetto
Necrotizing fasciitis (NF), a life-threatening rare infection of the soft tissues, is a medical and surgical emergency. It is characterized by subtle, rapid onset of spreading inflammation and necrosis starting from the fascia, muscles, and subcutaneous fat, with subsequent necrosis of the overlying skin. Once suspected, immediate and extensive radical debridement of necrotic tissues is mandatory. Appropriate antibiotics and intensive general support avoid massive systemic diffusion of the infective process and are the key for successful treatment. However, early diagnosis is missed or delayed in 85% to 100% of cases in large published series: because of the lack of specific clinical features in the initial stage of the disease, it is often underestimated or confused with cellulitis or abscess. Mortality rates are still high and have shown no tendency to decrease in the last 100 years. Unfortunately, the prevalence of the disease is such that physicians rarely become sufficiently confident with NF to be able to proceed with rapid diagnosis and management. This review covers the literature published in MEDLINE in the period 1970 to December 31, 2010. Particular attention is given to the clinical and laboratory elements to be considered for diagnosis. A wide variety of diagnostic tools have been described to facilitate and hasten the diagnosis of NF, but the most important tool for early diagnosis still remains a high index of clinical suspicion.

1 August 2011 in Burns
Verified
Journal Article
Closed access
LLL. Lancerotto
L. Lancerotto
RSR. Sferrazza
R. Sferrazza
AAA. Amabile
A. Amabile
BAB. Azzena
B. Azzena

1 April 2013 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
FBFranco M.D. Bassetto
Franco M.D. Bassetto
GTGiovanni M.D. Turra
Giovanni M.D. Turra
RSRoberto M.D. Salmaso
Roberto M.D. Salmaso
LLLuca M.D. Lancerotto
Luca M.D. Lancerotto
DVDaniel A. M.D. Del Vecchio
Daniel A. M.D. Del Vecchio
Background: No perfect solution yet exists for dermal fillers. The authors hypothesized that autologous dermis can be processed in an operator-friendly manner and adopted in selected patients as a filler, following the principle of replacing “like with like.” Methods: The authors designed a prototype “cutting chamber” to morsel dermis into an injectable form. Autologous injectable dermis grafting was performed in 16 patients who underwent lip or labionasal fold correction concomitant with abdominoplasty or cesarean scar correction; patient dermis was used for the donor graft. Furthermore, injectable dermis grafting was performed in the subcutaneous tissue of three patients undergoing multistage reconstructive procedures for obesity. The grafts were harvested and examined histologically at 3, 7, and 12 months. Results: Dermis processing and injection proved feasible with limited effort. All 16 patients presented good volume maintenance by 12 months. Two reported transient palpable firmness for the first 6 months, which subsequently resolved. Histological examination of processed and injected dermis showed volume maintenance over time, effective revascularization of the mass, and structural reorganization with collagen bundles and nested fibroblasts reminiscent of reticular dermis. A transient inflammatory reaction was observed, consistent with the expected healing events. Conclusions: Use of autologous dermis as a filler substance for both aesthetic and reconstructive procedures appears to be a feasible option. It could be advised for patients requiring filler correction who undergo concomitant procedures involving excision of potential donor dermis. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

1 March 2014 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
JLJorge R Lujan-Hernandez
Jorge R Lujan-Hernandez
LLLuca Lancerotto
Luca Lancerotto
CNChristoph Nabzdyk
Christoph Nabzdyk
KHKazi Z Hassan
Kazi Z Hassan
Roger K. KhouriRoger K. Khouri
Roger K. Khouri
DODennis P. Orgill
Dennis P. Orgill

1 April 2011
Verified
Journal Article
Closed access
VVVincenzo Vindigni
Vincenzo Vindigni
Franco BassettoFranco Bassetto
Franco Bassetto
SASilvio Abatangelo
Silvio Abatangelo
LPLaura Pandis
Laura Pandis
LLLuca Lancerotto
Luca Lancerotto
GAGiovanni Abatangelo
Giovanni Abatangelo

1 March 2014 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
LLLuca Lancerotto
Luca Lancerotto
MCMichael S. Chin
Michael S. Chin
BFBrian Freniere
Brian Freniere
JLJorge R. Lujan-Hernandez
Jorge R. Lujan-Hernandez
QLQiong Li
Qiong Li
DODennis P. Orgill
Dennis P. Orgill